News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,449 Results
Type
Article (5026)
Company Profile (17)
Press Release (220406)
Section
Business (82235)
Career Advice (465)
Deals (15049)
Drug Delivery (8)
Drug Development (19077)
Employer Resources (30)
FDA (3683)
Job Trends (3903)
News (120158)
Policy (7506)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (294)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14791)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3702)
Artificial intelligence (43)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2863)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (452)
Cardiovascular disease (24)
Career advice (396)
Career pathing (3)
CAR-T (32)
Cell therapy (106)
Cervical cancer (2)
Clinical research (16048)
Collaboration (172)
Compensation (170)
Complete response letters (2)
COVID-19 (305)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (525)
Depression (6)
Diabetes (43)
Diagnostics (2049)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40877)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37817)
Executive appointments (314)
FDA (3938)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (186)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (108)
Government (413)
Guidances (17)
Healthcare (5037)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (321)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (54)
IPO (7824)
IRA (3)
Job creations (1122)
Job search strategy (363)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2333)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (50)
MASH (28)
Medical device (3863)
Medtech (3864)
Mergers & acquisitions (7432)
Metabolic disorders (123)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (344)
NextGen: Class of 2025 (1677)
Non-profit (727)
Northern California (945)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (14)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (31)
Peanut (5)
People (24617)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4789)
Phase II (6970)
Phase III (5555)
Pipeline (565)
Policy (9)
Postmarket research (625)
Preclinical (1875)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1877)
Recruiting (8)
Regulatory (5123)
Reports (14)
Research institute (301)
Resumes & cover letters (69)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (712)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1008)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
United States (7144)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (42)
Last 7 days (211)
Last 30 days (721)
Last 365 days (9973)
2025 (3143)
2024 (11031)
2023 (13194)
2022 (18671)
2021 (19691)
2020 (18246)
2019 (13208)
2018 (10209)
2017 (10007)
2016 (9158)
2015 (12128)
2014 (9596)
2013 (7718)
2012 (8334)
2011 (8801)
2010 (8643)
Location
Africa (186)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11466)
Australia (1617)
California (1976)
Canada (712)
China (73)
Colorado (84)
Connecticut (94)
Delaware (30)
Europe (24556)
Florida (283)
Georgia (34)
Idaho (23)
Illinois (113)
India (7)
Indiana (64)
Iowa (2)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1582)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (570)
New Mexico (5)
New York (478)
North Carolina (330)
North Dakota (3)
Northern California (945)
Ohio (59)
Oklahoma (5)
Oregon (4)
Pennsylvania (349)
Puerto Rico (1)
Rhode Island (13)
South America (278)
South Carolina (5)
Southern California (712)
Tennessee (40)
Texas (229)
Utah (61)
Virginia (46)
Washington D.C. (9)
Washington State (175)
West Virginia (2)
Wisconsin (24)
225,449 Results for "luminex corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX® DATA ANALYSIS SOFTWARE
Bio-Techne Corporation (NASDAQ: TECH) today announced that R&D Systems®, a Bio-Techne brand, has released its new Quantist Luminex® data analysis software.
August 18, 2022
·
2 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Business
Luminex Corporation Reports Strong Third Quarter 2020 Results
Luminex Corporation announced results for its third quarter ended September 30, 2020.
November 5, 2020
·
13 min read
Business
Luminex Corporation Declares Second Quarter Cash Dividend - May 20, 2021
Luminex Corporation announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0.10 per share of common stock payable on July 8, 2021 to stockholders of record as of the close of business June 17, 2021.
May 20, 2021
·
1 min read
Business
Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021
Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter ended December 31, 2020 on Monday, February 8, 2021 .
January 27, 2021
·
1 min read
Lone Star Bio
Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference
Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, Chairman, CEO & President, and Harriss Currie, Senior Vice President and CFO, plan to participate at the 2021 Barclays Global Healthcare Conference on March 10, 2021 at 8:35 a.m. Eastern Time
March 9, 2021
·
1 min read
Deals
Luminex Corporation Declares First Quarter Cash Dividend
Luminex Corporation (Nasdaq:LMNX) (the “Company”) today announced that its board of directors declared a cash dividend for the first quarter of 2021 of $0.10 per share of common stock payable on April 15 , 2021 to stockholders of record as of the close of business March 25, 2021 .
February 8, 2021
·
1 min read
Press Releases
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
·
7 min read
1 of 22,545
Next
